Rebecca H. Johnson

Rebecca H. Johnson

Auto-generated profile, based on publicly available information

Rebecca H. Johnson

Mary Bridge Hospital/MultiCare Health System, Tacoma, WA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
RJRebecca H. Johnson
Rebecca H. Johnson
CACarey K. Anders
Carey K. Anders
JLJennifer K. Litton
Jennifer K. Litton
KRKathryn J. Ruddy
Kathryn J. Ruddy
ABArchie Bleyer
Archie Bleyer

1 June 2021 in JCO Oncology Practice
Verified
Journal Article
Closed access
ECElizabeth J. Cathcart-Rake
Elizabeth J. Cathcart-Rake
KRKathryn J. Ruddy
Kathryn J. Ruddy
ABArchie Bleyer
Archie Bleyer
RJRebecca H. Johnson
Rebecca H. Johnson
In the United States, one in 196 women is diagnosed with breast cancer under the age of 40 years. Adolescents and young adults (AYAs), of age 15-39 years at diagnosis, experience a number of unique challenges when confronting breast cancer. The incidence of invasive breast cancer has increased among AYA women in the United States since 2004, and most of this change is due to an increase in young women diagnosed with distant disease. AYAs are more likely than older women to present with aggressive subtypes and advanced disease, and they often require systemic staging at diagnosis. Clinical trials should be considered whenever possible, particularly in AYAs with locally advanced or metastatic disease at diagnosis and those with disease progression or recurrence. A significant proportion of AYAs carry germline cancer predisposition mutations, which necessitates prompt genetic testing for all AYAs at diagnosis and may influence choice of local therapy. Suppression of ovarian function, as an adjunct to chemotherapy, may improve breast cancer survival in AYAs. To provide optimal care for AYAs with breast cancer, clinicians should engage multidisciplinary teams that offer fertility preservation, genetic counseling, physical and occupational therapy, nutrition, and psychosocial support, along with medical expertise in tailoring cancer-directed therapy and symptom management toward young women.

16 September 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
MOMichael Osborn
Michael Osborn
RJRebecca Johnson
Rebecca Johnson
KTKate Thompson
Kate Thompson
AAAntoinette Catherine Anazodo
Antoinette Catherine Anazodo
KAKaren Albritton
Karen Albritton
DSDaniel Stark
Daniel Stark

9 May 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
RJRebecca H. Johnson
Rebecca H. Johnson
PHPingzhao Hu
Pingzhao Hu
CFCheng Fan
Cheng Fan
CACarey K. Anders
Carey K. Anders
Background: Young women with breast cancer experience inferior outcome and commonly manifest aggressive biological subtypes. Data is controversial regarding biological differences between breast tumors in young (diagnosed at <40 years of age) versus older women. We hypothesize there may be age-related expression differences in key genes for proliferation, invasion and metastasis within and across breast cancer subtypes, and that these differences correlate with outcome.

1 June 2021 in JCO Oncology Practice
Verified
Journal Article
Closed access
RJRebecca L. Jacobsen
Rebecca L. Jacobsen
CMCatherine Fiona Macpherson
Catherine Fiona Macpherson
BPBethann Mangel Pflugeisen
Bethann Mangel Pflugeisen
RJRebecca H. Johnson
Rebecca H. Johnson
PURPOSE: Most of the 77,000 adolescents and young adults (AYAs) 15-39 years of age diagnosed with cancer annually in the United States are treated at community rather than academic centers. Little is known about their healthcare experience. METHODS: A cross-sectional, anonymous, online survey was conducted with a convenience sample of AYAs treated for cancer at US academic (n = 112) or community centers (n = 64). RESULTS: Clinical trials were offered more frequently to respondents treated at academic centers (26.8% v 7.8%; P = .005). Eighty percent of all those offered a clinical trial chose to enroll. Over three-fourths reported awareness of community-based or online AYA oncology support services; however, significantly more respondents from academic centers reported awareness of services provided by the institution itself (40.2% v 7.8%; P < .001). Significantly more respondents from academic centers reported receiving information relevant to their age group (41.1% v 15.6%; P < .001). Respondents treated at academic centers were significantly more satisfied with support, communication, and overall treatment. Odds of respondents treated at an academic center reporting that their healthcare team knew enough about AYAs were 3.12-fold higher than those treated at community centers (95% CI, 1.6 to 6.4; P = .002). Odds of overall satisfaction were significantly higher for respondents who reported that their healthcare team “knew enough about AYAs” (aOR, 9.7, 95% CI, 2.4 to 53.9; P = .003). CONCLUSION: Cancer treatment for AYAs at both academic and community centers can be optimized by improving healthcare providers' understanding of the key issues facing AYAs with cancer and by increasing AYA-specific institutional resources and support services.

1 October 2019 in Journal of Adolescent and Young Adult Oncology
Verified
Journal Article
Closed access
BPBethann M. Pflugeisen
Bethann M. Pflugeisen
PPPandora Patterson
Pandora Patterson
CMCatherine F. Macpherson
Catherine F. Macpherson
BRBernadette C. Ray
Bernadette C. Ray
RJRebecca L. Jacobsen
Rebecca L. Jacobsen
RJRebecca H. Johnson
Rebecca H. Johnson
Purpose: This article describes the formation and first meeting of a community adolescent and young adult oncology council (AYAOC), which was created to promote patient and stakeholder involvement in research and programmatic initiatives within community-based cancer centers. Methods: The AYAOC (comprising patients/survivors, family members, researchers and clinicians) convened at a one-day workshop moderated by an Australian not-for-profit AYA cancer organization. The council shared and compared health care experiences and then identified and prioritized unmet health care needs. Workshop notes were analyzed using inductive content analysis. Results: AYAOC members identified similarities in their experiences of cancer care and priorities for improvement of the health care system. Peer connection and the creation of adolescent and young adult (AYA)-specific care facilities were identified as the most pressing needs for AYAs with cancer, closely followed by integration of complementary medicine into medical practice and government advocacy to improve the quality and consistency of AYA cancer care delivery. Themes identified from AYAOC discussion included emotional isolation, naivety with and sometimes distrust of the medical system, the lasting impact of cancer on identity, the need for emotionally safe interactions with both individual clinicians and groups of peers, and the desire to take personal action to improve care for future patients. Conclusion: AYAOC members expressed a drive to share their experiences, advocate for others, and improve health care services for the “next generation” of AYAs diagnosed with cancer. Sharing stories and connecting with peers may have personal value for individuals. Channeling the altruistic energy of AYAs and stakeholders into group advisory and advocacy efforts also has value for health care systems, allowing stakeholder insights to inform clinical service delivery and research priorities.